Inflammatory and
Immune-related disorders
-
Plain language summary of the VOLTAIRE-CD study in people with moderate-to-severe active Crohn’s disease
This plain language summary from Immunotherapy describes the VOLTAIRE-CD study, in which researchers compared BI 695501, a biosimilar to treat Crohn’s disease, with the original drug, adalimumab.
-
Plain language summary of the VOLTAIRE-RA study in patients with moderate-to-severe rheumatoid arthritis
The latest plain language summary of publication from Immunotherapy presents results from the VOLTAIRE-RA study looking at how effective and safe the biosimilar drug BI 695501 is in treating people with rheumatoid arthritis.